A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report

Contrast medium is frequently associated with allergic reactions and kidney dysfunction. However, contrast media can induce hemolytic anemia with a broad spectrum of hemolytic manifestations. We report a 38-year-old patient with very severe immune hemolytic anemia after the application of iomeprol d...

Full description

Saved in:
Bibliographic Details
Main Authors: Sabine Hermann, Karina Althaus, Migdat Mustafi, Beate Mayer, Peter Rosenberger, Helene Anna Haeberle, Alice Bernard
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1464014/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823859196516368384
author Sabine Hermann
Karina Althaus
Migdat Mustafi
Beate Mayer
Peter Rosenberger
Helene Anna Haeberle
Alice Bernard
author_facet Sabine Hermann
Karina Althaus
Migdat Mustafi
Beate Mayer
Peter Rosenberger
Helene Anna Haeberle
Alice Bernard
author_sort Sabine Hermann
collection DOAJ
description Contrast medium is frequently associated with allergic reactions and kidney dysfunction. However, contrast media can induce hemolytic anemia with a broad spectrum of hemolytic manifestations. We report a 38-year-old patient with very severe immune hemolytic anemia after the application of iomeprol due to a CT of the thorax/abdomen. In this case report, we illustrate the diagnostics and treatment of life-threatening hemolytic anemia induced by a contrast medium that was successfully treated with eculizumab.
format Article
id doaj-art-a3be422b92af49d6bc2ad92cc759c19d
institution Kabale University
issn 1664-3224
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-a3be422b92af49d6bc2ad92cc759c19d2025-02-11T06:59:46ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011610.3389/fimmu.2025.14640141464014A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case reportSabine Hermann0Karina Althaus1Migdat Mustafi2Beate Mayer3Peter Rosenberger4Helene Anna Haeberle5Alice Bernard6Department of Anaestesiology and Intensive Care Medicine, University Hospital Tuebingen, Tuebingen, GermanyClinical and Experimental Transfusion Medicine, University Hospital Tuebingen, Tuebingen, GermanyDepartment of Thoracic and Vascular Surgery, University Hospital Saarland, Saarbruecken, GermanyInsitutition of Transfusion Medicine, Charité, Berlin, GermanyDepartment of Anaestesiology and Intensive Care Medicine, University Hospital Tuebingen, Tuebingen, GermanyDepartment of Anaestesiology and Intensive Care Medicine, University Hospital Tuebingen, Tuebingen, GermanyDepartment of Anaestesiology and Intensive Care Medicine, University Hospital Tuebingen, Tuebingen, GermanyContrast medium is frequently associated with allergic reactions and kidney dysfunction. However, contrast media can induce hemolytic anemia with a broad spectrum of hemolytic manifestations. We report a 38-year-old patient with very severe immune hemolytic anemia after the application of iomeprol due to a CT of the thorax/abdomen. In this case report, we illustrate the diagnostics and treatment of life-threatening hemolytic anemia induced by a contrast medium that was successfully treated with eculizumab.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1464014/fulldrug-induced hemolysiscontrast medium-induced hemolysiseculizumabhemolytic anemiaimmunological hemolysis
spellingShingle Sabine Hermann
Karina Althaus
Migdat Mustafi
Beate Mayer
Peter Rosenberger
Helene Anna Haeberle
Alice Bernard
A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report
Frontiers in Immunology
drug-induced hemolysis
contrast medium-induced hemolysis
eculizumab
hemolytic anemia
immunological hemolysis
title A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report
title_full A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report
title_fullStr A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report
title_full_unstemmed A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report
title_short A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report
title_sort hyper acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab a case report
topic drug-induced hemolysis
contrast medium-induced hemolysis
eculizumab
hemolytic anemia
immunological hemolysis
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1464014/full
work_keys_str_mv AT sabinehermann ahyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT karinaalthaus ahyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT migdatmustafi ahyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT beatemayer ahyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT peterrosenberger ahyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT heleneannahaeberle ahyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT alicebernard ahyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT sabinehermann hyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT karinaalthaus hyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT migdatmustafi hyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT beatemayer hyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT peterrosenberger hyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT heleneannahaeberle hyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport
AT alicebernard hyperacuteimmunehemolyticanemiainducedbycontrastmediumwassuccessfullytreatedwitheculizumabacasereport